Answers are grounded in this paper and cite their sources.
To analyze the expression and clinical significance of LINC00877 in prostate cancer based on The Cancer Genome Atlas (TCGA) database and its relationship with immune infiltrates. The differential expression of LINC00877 and its association with clinical prognosis in prostate cancer were analyzed using TCGA datasets and validated with independent Gene Expression Omnibus (GEO) datasets. Gene Expression Profiling Interactive Analysis (GEPIA) was utilized to analyze overall survival (OS). Gene set enrichment analysis (GSEA) and single‐sample GSEA (ssGSEA) were conducted to analyze the correlation between LINC00877 and immune infiltrates. Gene Ontology (GO) function enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were used to analyze the related functions and pathway enrichment of differentially expressed genes. Furthermore, siRNA‐mediated knockdown of LINC00877 in prostate cancer cell lines was conducted to investigate the effects of LINC00877 on invasive capacity and cell cycle progression. LINC00877 was underexpressed in prostate cancer patients and associated with T stage and Gleason score. OS analysis revealed that prostate cancer patients with low expression of LINC00877 demonstrated worse prognosis. GSEA results showed that inflammatory response, KRAS, apoptosis, and the IL2/STAT5 signaling pathway were differentially enriched in prostate cancer samples. The KEGG and GO enrichment analysis showed that LINC00877 expression was found to be closely related to immune pathways. ssGSEA analysis found that LINC00877 expression correlated with the expression of tumor immune lymphocytes and immune checkpoint inhibitors. Knockdown of LINC00877 significantly promoted cell proliferation, enhanced invasion ability, and increased the S‐phase cell population in prostate cancer cells. LINC00877 serves as a potential prognostic biomarker and is implicated in tumor immunity. Functionally, siRNA‐mediated knockdown of LINC00877 in prostate cancer cells significantly promoted proliferation, enhanced invasion, and increased S‐phase cell cycle entry, suggesting an oncogenic role for LINC00877.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: